Epidemiology of urinary tract infections: Incidence, morbidity, and economic costs, Disease-a-Month, vol.49, issue.2, pp.53-70, 2003. ,
DOI : 10.1067/mda.2003.7
Diagnostic et antibiothérapie des infections urinaires bactériennes communautaires de l'adulte. Recommandations sur la prise en charge des infections urinaires de l'adulte. Disponible sur: http://www.infectiologie.com/site/medias French results of the ARESC Study: Clinical aspects and epidemiology of antimicrobial resistance in female patients with cystitis. Implications for empiric therapy, Médecine Mal Infect. févr, vol.42, issue.2, pp.66-75, 2012. ,
The ARESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections, International Journal of Antimicrobial Agents, vol.34, issue.5, pp.407-420, 2009. ,
DOI : 10.1016/j.ijantimicag.2009.04.012
URL : https://hal.archives-ouvertes.fr/hal-00556347
Résistances aux antibiotiques dans les infections urinaires communautaires en France métropolitaine, 22 novembre 2013. Communication orale. 7. Annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). Surveillance report. Antimicrobial resistance surveillance in Europe 2013, 2012. ,
Antimicrobial susceptibility of Escherichia coli from community-acquired urinary tract infections in Europe: the ECO??SENS study revisited, International Journal of Antimicrobial Agents, vol.39, issue.1, pp.45-51, 2012. ,
DOI : 10.1016/j.ijantimicag.2011.09.013
Increasing prevalence of esBl-producing enterobacteriaceae in Europe, Euro Surveill, vol.13, issue.47, 2008. ,
Réseau MedQual: surveillance de l'évolution des résistances des souches d'escherichia coli isolées en ville Comité de l'Antibiogramme de la Société Française de Microbiologie. European Committee on Antimicrobial Susceptibility Testing. Recommandations 2014 Disponible sur: http://www.sfmmicrobiologie .org/UserFiles/files/casfm/CASFM_EUCAST_V1_0_2014%281%29.pdf 14. Foxman B. Urinary Tract Infection Syndromes, 1?13. 15. Naber KG, Europe and Brazil on Clinical Aspects and Antimicrobial Resistance Epidemiology in Females with Cystitis (ARESC): Implications for Empiric Therapy, pp.21-25, 2008. ,
Urinary tract infections in women, Medical Clinics of North America, vol.88, issue.2, pp.417-446, 2004. ,
DOI : 10.1016/S0025-7125(03)00148-2
Epidemiology of prostatitis Urinary tract infections, Int J Antimicrob Agents. Dis Mon. févr, vol.3161, issue.182, pp.45-59, 2008. ,
Urinary tract infections: epidemiology, mechanisms of infection and treatment options, 269?84. 21. Zhanel GG, 2003. ,
DOI : 10.1038/nrmicro3432
Why fosfomycin trometamol as first line therapy for uncomplicated UTI?, International Journal of Antimicrobial Agents, vol.22 ,
DOI : 10.1016/S0924-8579(03)00231-0
Risk factors for resistance in urinary tract infections in women in general practice: A cross-sectional survey, Journal of Infection, vol.71, issue.3, pp.302-313, 2015. ,
DOI : 10.1016/j.jinf.2015.05.012
URL : https://hal.archives-ouvertes.fr/hal-01170431
Epidemiology of urinary tract infections, Clinical Microbiology Newsletter, vol.24, issue.18, 2002. ,
DOI : 10.1016/S0196-4399(02)80035-6
Acute bacterial prostatitis: heterogeneity in diagnostic criteria and management. Retrospective multicentric analysis of 371 patients diagnosed with acute prostatitis Den The Importance of Gender-Stratified Antibiotic Resistance Surveillance of Unselected Uropathogens: A Dutch Nationwide Extramural Surveillance Study. Thumbikat P, éditeur. PLoS ONE. 29 mars 2013 Urinary Tract Infection in Male General Practice Patients: Uropathogens and Antibiotic Susceptibility The microbiology of bacteriuria in men: a 5- year study at a Veterans' Affairs hospital, 336?40. 28. Cornia PB, pp.12-26, 2006. ,
Emerging antibiotic resistance in urinary tract pathogens Empiric use of trimethoprim-sulfamethoxazole (TMP-SMX) in the treatment of women with uncomplicated urinary tract infections, in a geographical area with a high prevalence of TMP- SMX?resistant uropathogens, 243?59. 32. Raz R, pp.1165-1174, 2002. ,
Antibiotic treatment of acute uncomplicated cystitis based on rapid urine test and local epidemiology: lessons from a primary care series, BMC Infectious Diseases, vol.67, issue.1, p.137, 2014. ,
DOI : 10.1093/jac/dks222
Journées nationales d'infectiologie 2013 Epidemiology and Clinical Features of Infections Caused by Extended- Spectrum Beta-Lactamase-Producing Escherichia coli in Nonhospitalized Patients, Antibiothérapie probabiliste des pyélonéphrites aiguës hospitalisées en infectiologie: état des résistances et facteurs prédictifs. Poster, pp.1089-94, 2004. ,
Epidemiology and Risk Factors of Community Onset Infections Caused by Extended-Spectrum ??-Lactamase-Producing Escherichia coli Strains, Journal of Clinical Microbiology, vol.50, issue.2, pp.312-319, 2012. ,
DOI : 10.1128/JCM.06002-11
Extended-spectrum ?-lactamaseproducing Gram-negative pathogens in community-acquired urinary tract infections: an increasing challenge for antimicrobial therapy Urinary tract infections due to extended-spectrum beta-lactamase-producing Gram-negative bacteria: identification of risk factors and outcome predictors in an Australian tertiary referral hospital, 333?40. 38. Osthoff M, pp.79-83, 2011. ,
A Multinational Survey of Risk Factors for Infection with Extended???Spectrum ?????Lactamase???Producing Enterobacteriaceae in Nonhospitalized Patients, Clinical Infectious Diseases, vol.49, issue.5, pp.682-90, 2009. ,
DOI : 10.1086/604713
URL : https://hal.archives-ouvertes.fr/hal-00426315
Entérobactéries productrices de bêta-lactamases à spectre élargi : épidémiologie, facteurs de risque et mesures de prévention. Rev Médecine Interne Community infections caused by extended-spectrum ?-lactamase?producing Escherichia coli Risk Factors for Community-Acquired Urinary Tract Infections Caused by ESBL-Producing Enterobacteriaceae ?A Case?Control Study in a Low Prevalence Country, Calbo E. Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum -lactamases1897?902. 43. Søraas A, Sundsfjord A al. Risk Factors for the Development of Extended-Spectrum Beta-Lactamase-Producing Bacteria in Nonhospitalized Patients, pp.69581-44163, 2004. ,
AST) pour les VITEK ® 2 Systems est une méthode de test automatique qui repose sur la technique de détermination de la concentration minimale inhibitrice (CMI) rapportée par MacLowry et Marsh (1) et Gerlach (2). La carte d'antibiogramme est une version miniaturisée et abrégée de la ,